Oral absorption of riboflavin dosed by a floating multiple-unit system in different feeding conditions

Journal of Drug Delivery Science and Technology

Volumn 14, Issue 2, 2004, Pages 127-133

  Iannuccelli, V ^a   Sala, N ^a   Sergi, S ^a   Coppi, G ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Calcium alginate; Floating dosage form; Oral absorption; Riboflavin; Urinary excretion

Indexed keywords

CALCIUM ALGINATE; FLAVINE MONONUCLEOTIDE; POLYVINYL ALCOHOL; RIBOFLAVIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG URINE LEVEL; FEMALE; HUMAN; MALE; MEAL; RANDOMIZED CONTROLLED TRIAL; SMALL INTESTINE; STOMACH; URINARY EXCRETION;

EID: 1942505823     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1773-2247(04)50024-2     Document Type: Article

References (16)

1. DESAI S., BOLTON S. - A floating controlled-release drug delivery system: in vitro-in vivo evaluation. - Pharm. Res., 10, 1321-1325, 1993.
2. MENON A., RITSCHEL W.A., SAKR A. - Development and evaluation of a monolithic floating dosage form for furosemide. - J. Pharm. Sci., 83, 239-245, 1994.
3. TIMMERMANS J., MOËS A.J. - Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy. - J. Pharm. Sci., 83, 18-24, 1994.
4. LEUCUTA S.E., FOLLIDIS M., CAPALNEANU R., MOCAN A. - Relative bioavailability of different oral sustained release oxprenolol tablets. - Eur. J. Drug Metab. Pharmacokinet., 23, 178-184, 1998.
5. CHIEN Y.W. - Oral drug delivery and delivery systems. - In: Novel Drug Delivery Systems, J. Swarbrick Ed., Marcel Dekker, New York, 1992, pp. 139-192.
6. INGANI H.M., TIMMERMANS J., MOËS A.J. - Conception and in vivo investigation of peroral sustained release floating dosage forms with enhanced gastrointestinal transit. - Int. J. Pharm., 35, 157-164, 1987.
7. KAWASHIMA Y., NIWA T., TAKEUCHI H., HINO T., ITOH Y. - Hollow microspheres for use as a floating controlled drug delivery system in the stomach. - J. Pharm. Sci., 81, 135-140, 1992.
8. MURATA Y, SASAKI N., MIYAMOTO E., KAWASHIMA S. - Use of floating alginate gel beads for stomach-specific drug delivery. - Eur. J. Pharm. Biopharm., 50, 221-226, 2000.
9. IANNUCCELLI V., COPPI G., BERNABEI M.T., CAMERONI R. - Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study. - Int. J. Pharm., 174, 47-54, 1998.
10. IANNUCCELLI V., COPPI G., SANSONE R., FEROLLA G. - Air compartment multiple-unit system for prolonged gastric residence. Part II. In vivo evaluation. - Int. J. Pharm., 174, 55-62, 1998.
11. IANNUCCELLI V., COPPI G., LEO E., FONTANA F., BERNABEI M.T. - PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system. - Drug. Dev. Ind. Pharm., 26, 595-603, 2000.
12. JUSKO W.J., LEVY G. - Absorption, metabolism and excretion of riboflavin-5′-phosphate in man. - J. Pharm. Sci., 56, 58-62, 1967.
13. BURCH H.B., BESSEY O.A., LOWRY O.H. - Fluorimetric measurements of riboflavin and its natural derivatives in small quantities of blood, serum and cells. - J. Biol. Chem., 175, 457-470, 1948.
14. HAUG A., LARSEN B., SMIDSRÖD O. - The degradation of alginates at different pH values. - Acta Chem. Scand., 17, 1466-1468, 1963.
15. MCDOWELL R.H. - Properties of alginates. - Kelco International, Bagnolet, 1986, p. 43.
16. TØNNESEN H.H., KARLSEN J. - Alginate in drug delivery systems. - Drug Dev. Ind. Pharm., 28, 621-630, 2002.